New insights from the AI-ENCODE study showed artificial intelligence (AI) successfully allowed the automated extraction of key functional and physiological data from routine angiograms.
A recent study led by UC Davis Health researchers provides new insights into the molecular changes linked to the rare genetic condition 22q11.2 deletion syndrome, or 22q.
UCL academics will co-lead Prostate Cancer UK's new £42m screening trial, which aims to find the best way to screen men for prostate cancer and double the number of lives saved.